Bristol Myers Squibb · 2 days ago
Clinical Development Lead (Senior Director), Oncology
Princeton, NJ
Full-time
Onsite
Director/Executive
$351K/yr - $425K/yr
10+ years expBristol Myers Squibb is a company dedicated to transforming patients' lives through science. They are seeking a Clinical Development Lead (Senior Director) in Oncology, responsible for overseeing the clinical development strategy and execution of clinical trials, while leading and mentoring a team of Clinical Trial Physicians.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Accountable for the clinical contribution to the development of each indication strategy, including registrational and non-registrational studies, with the support of the CTPs and Clinical Scientists (CS) within the asset and/or indication
Responsible for managing clinical trial physician(s); attracting, developing and retaining top talent; ensuring appropriate training and mentoring of clinical trial physicians
May serve as CTP as necessary
Accountable in partnership with the Clinical Scientist for the design, execution, and analyses of each study led by the CTPs and CSs. Should work to proactively partner with these roles
Accountable for clinical content for CSRs, regulatory reports, briefing books and submission documents
Champions a quality-focused mindset and ensures adherence to GCP and compliance obligations for clinical conduct
Represents Clinical Development in both internal and external forums as the consulted authority for the disease area, including within Business Development function
Partners with Worldwide Patient Safety physicians in the ongoing review of safety data
Serves as the (co-)leader of the cross-functional Clinical Development Team
Provides clinical leadership and disease area expertise into integrated disease area strategies
Partners closely with KOLs in specific indications
Serves as Primary Clinical Representative in Regulatory interactions
Evaluates strategic options against a given Target Product Profile (TPP)
Collaborates with Global Development Operations/Global Compliance Group to develop asset level risk management plan, resolves issues with Quality/CS, and raises to DT as needed
Sets executional priorities and partners with CTP and CS to support executional delivery of studies
Accountable for top line data with support of CTP, CS, and Statisticians
Qualification
Required
MD required with a deep understanding of the clinical principles of the area of interest or equivalent therapy area knowledge
At least 10 years of relevant experience
CDL Has Demonstrated Leadership In The Design And Execution Of Multiple Clinical Trials (e.g. Significant Experience As a Senior Clinical Leader)
Able to synthesize internal and external data to produce a clinical strategy
Able to ensure that the clinical program will result in a viable registrational strategy
Able to assess personnel needs, translate into a hiring strategy, and lead the hiring efforts
Able to work with other stakeholders to ensure a robust enterprise level strategy for asset(s) and indication(s) including early, late and post-marketing development, as well as awareness of the enterprise disease area portfolio
CDL has demonstrated, sustained excellent performance as Clinical Trial Physician, Clinical Scientist, or equivalent
Verifiable track record of successful people management and development, or leadership in a matrix team (e.g. mentoring junior colleagues)
CDL has demonstrated excellent skills in clinical development strategy including the clinical components of regulatory submission(s)
External focus to understand the trends in the disease area treatment paradigms and ability to build relationships with external partners, thought leaders and collaborators outside of BMS
Partner and interact with colleagues from Early Development who design and implement first in human through proof of concept trials and will to assure a seamless transition into late stage development (Phase II-III trials)
Ability to lead and develop a group of CTPs to ensure scientific and technical excellence of clinical development programs and deliverables
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
MedCity News
2026-01-06
Dallas Morning News
2026-01-05
2025-12-30
Company data provided by crunchbase